Two Sigma Advisers
LLY icon

Two Sigma Advisers’s Eli Lilly LLY Stock Holding History

Two Sigma Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-8,000
Closed -$497K – 2522
2014
Q2 		$497K Buy
8,000
+4,000
+100% +$239K ﹤0.01% 1696
2014
Q1 		$235K Sell
4,000
-19,000
-83% -$1.06M ﹤0.01% 2027
2013
Q4 		$1.17M Sell
23,000
-44,000
-66% -$2.2M 0.01% 1055
2013
Q3 		$3.37M Buy
+67,000
New +$3.51M 0.04% 437

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Two Sigma Advisers's LLY Position: Q1 2026 in Review

Two Sigma Advisers sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 5,380 shares — an estimated $5.78M sold.

Two Sigma Advisers first reported a position in LLY in Q2 2013 and held it in 45 quarters. The position peaked at $681M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Two Sigma Advisers reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 5,380 Eli Lilly shares in Q1 2026, an estimated $5.78M.
  • Two Sigma Advisers first reported a position in Eli Lilly in Q2 2013 and held it in 45 quarters.
  • Two Sigma Advisers's Eli Lilly position peaked at $681M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.